Sio Capital Management’s Immunic IMUX Stock Holding History

Sio Capital Management’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-487	Closed	-$54K	–	78
2018 Q3	$54K	Buy	487 +452	+1,291%	+$1.18M	0.02%	62
2018 Q2	$95K	Buy	+35	New	+$80.9K	0.05%	49

Other funds holding IMUX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Sio Capital Management's IMUX Position: Q4 2018 in Review

Sio Capital Management sold out of Immunic (IMUX) in Q4 2018, closing a stake of 259 shares — an estimated $29K sold.

Sio Capital Management first reported a position in IMUX in Q3 2018 and held it in 1 quarter. The position peaked at $29K in Q3 2018. 47 funds tracked by Wall St. Rank hold IMUX as of Q4 2018.

Sio Capital Management reported no remaining Immunic position as of Q4 2018 after selling out during the quarter.
Sio Capital Management sold 259 Immunic shares in Q4 2018, an estimated $29K.
Sio Capital Management first reported a position in Immunic in Q3 2018 and held it in 1 quarter.
Sio Capital Management's Immunic position peaked at $29K in Q3 2018.
47 funds tracked by Wall St. Rank held Immunic as of Q4 2018.

Based on Sio Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.